Detected ·

PANDA Therapeutics

CHF 150K—

PANDA Therapeutics received CHF 150,000 from Venture Kick (Stage III funding) to advance its multi-target, antibody-based Alzheimer’s therapy targeting amyloid-beta and tau.

Website
—
LinkedIn
—
Amount
CHF 150 000 CHF
Stage
—
Event
Funding round
Detected
2026-09-01 04:06:49 UTC
Signal ID
40728f67-8dd7-433c-8b0d-f6bebb437674

As the API returns it

{
  "id": "40728f67-8dd7-433c-8b0d-f6bebb437674",
  "created_at": "2026-09-01T04:06:49.763133Z",
  "company_name": "PANDA Therapeutics",
  "company_website_url": null,
  "company_linkedin_url": null,
  "event_type": "funding",
  "funding_amount": 150000,
  "funding_currency": "CHF",
  "funding_stage": null,
  "message": "*PANDA Therapeutics received CHF 150,000 from Venture Kick (Stage III funding) to advance its multi-target, antibody-based Alzheimer’s therapy targeting amyloid-beta and tau.*"
}

Latest rounds